Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor

Brain Research

Volumn 1344, Issue , 2010, Pages 124-133

  Washington, Martha C ^a   Raboin, Shannon J ^a   Thompson, William ^a   Larsen, Christina J ^a   Sayegh, Ayman I ^a  

^a Nursing and Allied Health   (United States)

Author keywords

Fos; GLP 1; Myenteric plexus; Satiety; Submucosal plexus

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; FOOD DEPRIVATION; FOOD INTAKE; INTESTINE INNERVATION; MALE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; RAT; RHOMBENCEPHALON;

ANALYSIS OF VARIANCE; ANIMALS; EATING; GASTROINTESTINAL TRACT; HYPOGLYCEMIC AGENTS; MALE; MEDULLA OBLONGATA; NEURONS; ONCOGENE PROTEINS V-FOS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCAGON; VENOMS;

RATTUS;

EID: 77953915094     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.05.002     Document Type: Article

References (37)

1. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., Ghatei M.A., and Bloom S.R. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 1044 (2005) 127-131
2. Al-Barazanji K.A., Arch J.R., Buckingham R.E., and Tadayyon M. Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats. Obes. Res. 8 (2000) 317-323
3. Aziz A., and Anderson G.H. Exendin-4, a GLP-1 receptor agonist, modulates the effect of macronutrients on food intake by rats. J. Nutr. 132 (2002) 990-995
4. Baggio L.L., Huang Q., Brown T.J., and Drucker D.J. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127 (2004) 546-558
5. Bataille D., Tatemoto K., Gespach C., Jornvall H., Rosselin G., and Mutt V. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett. 146 (1982) 79-86
6. Berthoud H.R., Blackshaw L.A., Brookes S.J., and Grundy D. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 16 Suppl 1 (2004) 28-33
7. Bond A. Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus. Proc (Bayl Univ Med Cent) 19 (2006) 281-284
8. Bucinskaite V., Tolessa T., Pedersen J., Rydqvist B., Zerihun L., Holst J.J., and Hellstrom P.M. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol. Motil. 21 (2009) 978-e978
9. Damholt A.B., Buchan A.M., and Kofod H. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose. Endocrinology 139 (1998) 2085-2091
10. Deacon C.F., Hughes T.E., and Holst J.J. Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes 47 (1998) 764-769
11. Eng J., Kleinman W.A., Singh L., Singh G., and Raufman J.P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J. Biol. Chem. 267 (1992) 7402-7405
12. Goke R., Fehmann H.C., Linn T., Schmidt H., Krause M., Eng J., and Goke B. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J. Biol. Chem. 268 (1993) 19650-19655
13. Grundy D. What activates visceral afferents?. Gut 53 Suppl 2 (2004) ii5-ii8
14. Hargrove D.M., Kendall E.S., Reynolds J.M., Lwin A.N., Herich J.P., Smith P.A., Gedulin B.R., Flanagan S.D., Jodka C.M., Hoyt J.A., McCowen K.M., Parkes D.G., and Anderson C.M. Biological activity of AC3174, a peptide analog of exendin-4. Regul. Pept. 141 (2007) 113-119
15. Hayes M.R., Skibicka K.P., and Grill H.J. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology 149 (2008) 4059-4068
16. Hira T., Mochida T., Miyashita K., and Hara H. GLP-1 secretion is enhanced directly in the ileum, but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate in rats. Am. J. Physiol. Gastrointest. Liver Physiol. (2009)
17. Holmes G.M., Browning K.N., Tong M., Qualls-Creekmore E., and Travagli R.A. Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions. J. Physiol. 587 (2009) 4749-4759
18. Imeryuz N., Yegen B.C., Bozkurt A., Coskun T., Villanueva-Penacarrillo M.L., and Ulusoy N.B. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am. J. Physiol. 273 (1997) G920-G927
19. Kakei M., Yada T., Nakagawa A., and Nakabayashi H. Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons. Auton. Neurosci. 102 (2002) 39-44
20. Kastin A.J., and Akerstrom V. Entry of exendin-4 into brain is rapid but may be limited at high doses. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 313-318
21. Mack C.M., Moore C.X., Jodka C.M., Bhavsar S., Wilson J.K., Hoyt J.A., Roan J.L., Vu C., Laugero K.D., Parkes D.G., and Young A.A. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Int. J. Obes (London) 30 (2006) 1332-1340
22. Murphy M.C., and Fox E.A. Anterograde tracing method using DiI to label vagal innervation of the embryonic and early postnatal mouse gastrointestinal tract. J. Neurosci. Meth. 163 (2007) 213-225
23. Nakagawa A., Satake H., Nakabayashi H., Nishizawa M., Furuya K., Nakano S., Kigoshi T., Nakayama K., and Uchida K. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton. Neurosci. 110 (2004) 36-43
24. Paxinos G., and Tork I. Neuroanatomical nomenclature. Trends Neurosci. 13 (1990) 169
25. Paxinos G., Watson C., Pennisi M., and Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J. Neurosci. Meth. 13 (1985) 139-143
26. Rai A., Singh G., Raffaniello R., Eng J., and Raufman J.P. Actions of Helodermatidae venom peptides and mammalian glucagon-like peptides on gastric chief cells. Am. J. Physiol. 265 (1993) G118-G125
27. Rodriquez de Fonseca F., Navarro M., Alvarez E., Roncero I., Chowen J.A., Maestre O., Gomez R., Munoz R.M., Eng J., and Blazquez E. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism 49 (2000) 709-717
28. Ruttimann E.B., Arnold M., Hillebrand J.J., Geary N., and Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 150 (2009) 1174-1181
29. Sayegh A.I., Reeve Jr. J.R., Lampley S.T., Hart B., Gulley S., Esdaile A.R., Sharma S.K., Webb T., Williams C.S., and Pruitt F. Role for the enteric nervous system in the regulation of satiety via cholecystokinin-8. J. Am. Vet. Med. Assoc. 226 (2005) 1809-1816
30. Schmidt W.E., Siegel E.G., and Creutzfeldt W. Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28 (1985) 704-707
31. Scott K.A., and Moran T.H. The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R983-R987
32. Szayna M., Doyle M.E., Betkey J.A., Holloway H.W., Spencer R.G., Greig N.H., and Egan J.M. Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology 141 (2000) 1936-1941
33. Talsania T., Anini Y., Siu S., Drucker D.J., and Brubaker P.L. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146 (2005) 3748-3756
34. Tan L.L., Bornstein J.C., and Anderson C.R. Neurochemical and morphological phenotypes of vagal afferent neurons innervating the adult mouse jejunum. Neurogastroenterol. Motil. (2009)
35. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., Wilding J.P., Smith D.M., Ghatei M.A., Herbert J., and Bloom S.R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 (1996) 69-72
36. Williams D.L., Baskin D.G., and Schwartz M.W. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 55 (2006) 3387-3393
37. Yamamoto H., Lee C.E., Marcus J.N., Williams T.D., Overton J.M., Lopez M.E., Hollenberg A.N., Baggio L., Saper C.B., Drucker D.J., and Elmquist J.K. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J. Clin. Invest. 110 (2002) 43-52